| The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer C Parr, G Watkins, WG Jiang International journal of molecular medicine 14 (5), 779-786, 2004 | 364 | 2004 |
| Hepatocyte growth factor, its receptor, and their potential value in cancer therapies WG Jiang, TA Martin, C Parr, G Davies, K Matsumoto, T Nakamura Critical reviews in oncology/hematology 53 (1), 35-69, 2005 | 362 | 2005 |
| Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human … H Kang, G Watkins, C Parr, A Douglas-Jones, RE Mansel, WG Jiang Breast Cancer Research 7, 1-9, 2005 | 251 | 2005 |
| The hepatocyte growth factor regulatory factors in human breast cancer C Parr, G Watkins, RE Mansel, WG Jiang Clinical cancer research 10 (1), 202-211, 2004 | 246 | 2004 |
| Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis PL White, C Parr, C Thornton, RA Barnes Journal of clinical microbiology 51 (5), 1510-1516, 2013 | 179 | 2013 |
| Placenta growth factor is over-expressed and has prognostic value in human breast cancer C Parr, G Watkins, M Boulton, J Cai, WG Jiang European Journal of Cancer 41 (18), 2819-2827, 2005 | 166 | 2005 |
| Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer C Parr, WG Jiang European journal of cancer 45 (9), 1673-1683, 2009 | 156 | 2009 |
| Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells WG Jiang, G Davies, TA Martin, C Parr, G Watkins, MD Mason, RE Mansel International journal of molecular medicine 17 (4), 583-590, 2006 | 155 | 2006 |
| Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy WG Jiang, G Davies, TA Martin, C Parr, G Watkins, MD Mason, K Mokbel, ... Clinical Cancer Research 11 (16), 6012-6019, 2005 | 144 | 2005 |
| Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells C Parr, WG Jiang International journal of oncology 19 (4), 857-863, 2001 | 143 | 2001 |
| Antagonistic Effect of NK4, a Novel Hepatocyte Growth Factor Variant, on in Vitro Angiogenesis of Human Vascular Endothelial Cells WG Jiang, SE Hiscox, C Parr, TA Martin, K Matsumoto, T Nakamura, ... Clinical Cancer Research 5 (11), 3695-3703, 1999 | 134 | 1999 |
| Quantitative analysis of lymphangiogenic markers in human colorectal cancer C Parr, WG Jiang International journal of oncology 23 (2), 533-539, 2003 | 124 | 2003 |
| Biphasic effects of 17‐β‐estradiol on expression of occludin and transendothelial resistance and paracellular permeability in human vascular endothelial cells L Ye, TA Martin, C Parr, GM Harrison, RE Mansel, WG Jiang Journal of cellular physiology 196 (2), 362-369, 2003 | 123 | 2003 |
| Nk4, a new HGF/SF variant, is an antagonist to the influence of HGF/SF on the motility and invasion of colon cancer cells C Parr, S Hiscox, T Nakamura, K Matsumoto, WG Jiang International journal of cancer 85 (4), 563-570, 2000 | 115 | 2000 |
| Hepatocyte growth factor activation inhibitors (HAI‐1 and HAI‐2) regulate HGF‐induced invasion of human breast cancer cells C Parr, WG Jiang International journal of cancer 119 (5), 1176-1183, 2006 | 109 | 2006 |
| Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist TA Martin, C Parr, G Davies, G Watkins, J Lane, K Matsumoto, ... Carcinogenesis 24 (8), 1317-1323, 2003 | 106 | 2003 |
| Decreased pigment epithelium–derived factor expression in human breast cancer progression J Cai, C Parr, G Watkins, WG Jiang, M Boulton Clinical Cancer Research 12 (11), 3510-3517, 2006 | 95 | 2006 |
| Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications SR Davies, ML Davies, A Sanders, C Parr, J Torkington, WG Jiang International journal of oncology 36 (5), 1129-1136, 2010 | 88 | 2010 |
| Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET WG Jiang, D Grimshaw, TA Martin, G Davies, C Parr, G Watkins, J Lane, ... Clinical Cancer Research 9 (11), 4274-4281, 2003 | 79 | 2003 |
| The HGF/SF antagonist NK4 reverses fibroblast‐and HGF‐induced prostate tumor growth and angiogenesis in vivo G Davies, MD Mason, TA Martin, C Parr, G Watkins, J Lane, K Matsumoto, ... International journal of cancer 106 (3), 348-354, 2003 | 74 | 2003 |
